SNGX
SOLIGENIX, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.34
−2.66%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-154.1%
Return on equity
-97.5%
Return on assets
-158.9%
Return on invested capital
0.00x
Asset turnover
-$9.7M
Cash from operations
$0.45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026